+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Kyowa Kirin Co Ltd (4151) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 67 Pages
  • April 2023
  • GlobalData
  • ID: 1367862
Kyowa Kirin Co Ltd (4151) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Kyowa Kirin Co Ltd (Kyowa Kirin), a subsidiary of Kirin Holdings Co Ltd, is a biotechnology company focused on research and development. It is involved in the discovery, development, production and commercialization of pharmaceuticals and biotechnology products. The company offers drugs in the areas of nephrology, oncology, immunology and allergy, central nervous system among others. Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, angina pectoris, hypertension, allergic rhinitis, epilepsy, behavioral or personality disorders and others. The company operates through a network of subsidiaries in the US, Europe and Asia. Kyowa Kirin is headquartered in Tokyo, Japan.

Kyowa Kirin Co Ltd Key Recent Developments

  • Mar 28, 2023: Kyowa Kirin completed construction of a new office building at Ube plant
  • Feb 07, 2023: Kyowa Kirin Announces Consolidated Financial Summary for Fiscal Year Ended December 31, 2022
  • Dec 22, 2022: Kyowa Kirin to decide on construction of a new warehouse building at its Takasaki Plant
  • Dec 22, 2022: Kyowa Kirin’s Ube plant to introduce large-scale solar power generation system

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Kyowa Kirin Co Ltd - Key Facts
  • Kyowa Kirin Co Ltd - Key Employees
  • Kyowa Kirin Co Ltd - Key Employee Biographies
  • Kyowa Kirin Co Ltd - Major Products and Services
  • Kyowa Kirin Co Ltd - History
  • Kyowa Kirin Co Ltd - Company Statement
  • Kyowa Kirin Co Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Kyowa Kirin Co Ltd - Business Description
  • Product Category: Licenses
  • Performance
  • Product Category: Products
  • Performance
  • Geographical Segment: Americas
  • Performance
  • Geographical Segment: Asia
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Japan
  • Performance
  • Geographical Segment: Other
  • Performance
  • R&D Overview
  • Kyowa Kirin Co Ltd - Corporate Strategy
  • Kyowa Kirin Co Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Kyowa Kirin Co Ltd - Strengths
  • Kyowa Kirin Co Ltd - Weaknesses
  • Kyowa Kirin Co Ltd - Opportunities
  • Kyowa Kirin Co Ltd - Threats
  • Kyowa Kirin Co Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Kyowa Kirin Co Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 28, 2023: Kyowa Kirin completed construction of a new office building at Ube plant
  • Feb 07, 2023: Kyowa Kirin Announces Consolidated Financial Summary for Fiscal Year Ended December 31, 2022
  • Dec 22, 2022: Kyowa Kirin to decide on construction of a new warehouse building at its Takasaki Plant
  • Dec 22, 2022: Kyowa Kirin’s Ube plant to introduce large-scale solar power generation system
  • Dec 20, 2022: Kyowa Kirin and GENESIS Pharma announce their partnership for an orphan drug portfolio in Greece, Cyprus and Malta
  • Dec 05, 2022: MEI Pharma initiates strategic realignment
  • Nov 08, 2022: Kyowa Kirin appoints Abdul Mullick, President, Kyowa Kirin International, to New Global Role as Vice Chief International Business Officer; Jeremy Morgan appointed President, Kyowa Kirin International
  • Aug 26, 2022: Kyowa Kirin announces changes to its organization
  • Aug 04, 2022: Kyowa Kirin Co. Announces Consolidated Financial Results for the Six Months Ended June 30, 2022
  • May 17, 2022: Kyowa Kirin to start construction of a new biopharmaceutical API manufacturing building at its Takasaki plant
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Kyowa Kirin Co Ltd, Key Facts
  • Kyowa Kirin Co Ltd, Key Employees
  • Kyowa Kirin Co Ltd, Key Employee Biographies
  • Kyowa Kirin Co Ltd, Major Products and Services
  • Kyowa Kirin Co Ltd, History
  • Kyowa Kirin Co Ltd, Other Locations
  • Kyowa Kirin Co Ltd, Subsidiaries
  • Kyowa Kirin Co Ltd, Joint Venture
  • Kyowa Kirin Co Ltd, Key Competitors
  • Kyowa Kirin Co Ltd, Ratios based on current share price
  • Kyowa Kirin Co Ltd, Annual Ratios
  • Kyowa Kirin Co Ltd, Interim Ratios
  • Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Kyowa Kirin Co Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Kyowa Kirin Co Ltd, Performance Chart (2018 - 2022)
  • Kyowa Kirin Co Ltd, Ratio Charts
  • Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Chugai Pharmaceutical Co Ltd
  • Takeda Pharmaceutical Co Ltd
  • Kaken Pharmaceutical Co Ltd
  • Eisai Co Ltd
  • Taisho Pharmaceutical Holdings Co Ltd
  • Takeda Pharmaceutical Co Ltd
  • Kaken Pharmaceutical Co Ltd
  • Eisai Co Ltd
  • Chugai Pharmaceutical Co Ltd
  • Taisho Pharmaceutical Holdings Co Ltd